Literature DB >> 6651017

Single-cell DNA measurement in hyperplastic, dysplastic and carcinomatous laryngeal epithelia, with special reference to the occurrence of hypertetraploid cell nuclei.

K Bjelkenkrantz, J Lundgren, J Olofsson.   

Abstract

Single-cell DNA fluorometry was performed on smear preparations from 57 histologically verified lesions from the vocal cords. Special attention was paid to the detection of hypertetraploid cell nuclei, which may be considered neoplastic markers, since they are not present in normal vocal cord epithelium. Hypertetraploid nuclei were not found in hyperplastic or mildly dysplastic epithelia but were found in 4 of 14 specimens of moderate dysplasia and in 5 of 19 specimens of severe dysplasia. The presence of hypertetraploid nuclei was associated with more frequent recurrences and progression of disease. Hypertetraploid cell nuclei were found in 9 of 15 invasive carcinomas and in this group were associated with a worse prognosis. The proliferative activity was 1.7% for hyperplasia and mild dysplasia, 3.1% and 2.8%, respectively, for moderate and severe dysplasia and 7.6% for squamous-cell carcinoma.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6651017

Source DB:  PubMed          Journal:  Anal Quant Cytol        ISSN: 0190-0471


  3 in total

1.  An evaluation of Feulgen-acriflavine-SO2 and Hoechst 33258 for DNA cytofluorometry in tumour pathology.

Authors:  K Bjelkenkrantz
Journal:  Histochemistry       Date:  1983

2.  Inhibition of Chk1 kills tetraploid tumor cells through a p53-dependent pathway.

Authors:  Ilio Vitale; Lorenzo Galluzzi; Sonia Vivet; Lisa Nanty; Philippe Dessen; Laura Senovilla; Ken A Olaussen; Vladimir Lazar; Michelle Prudhomme; Roy M Golsteyn; Maria Castedo; Guido Kroemer
Journal:  PLoS One       Date:  2007-12-26       Impact factor: 3.240

3.  DNA content, malignancy grading and prognosis in T1 and T2 oral cavity carcinomas.

Authors:  M Tytor; G Franzén; J Olofsson; U Brunk; B Nordenskjöld
Journal:  Br J Cancer       Date:  1987-11       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.